AU2001278755A1 - Injections - Google Patents
InjectionsInfo
- Publication number
- AU2001278755A1 AU2001278755A1 AU2001278755A AU7875501A AU2001278755A1 AU 2001278755 A1 AU2001278755 A1 AU 2001278755A1 AU 2001278755 A AU2001278755 A AU 2001278755A AU 7875501 A AU7875501 A AU 7875501A AU 2001278755 A1 AU2001278755 A1 AU 2001278755A1
- Authority
- AU
- Australia
- Prior art keywords
- injections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-248468 | 2000-08-18 | ||
JP2000248468 | 2000-08-18 | ||
PCT/JP2001/007075 WO2002015908A1 (en) | 2000-08-18 | 2001-08-17 | Injections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001278755A1 true AU2001278755A1 (en) | 2002-03-04 |
Family
ID=18738370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001278755A Abandoned AU2001278755A1 (en) | 2000-08-18 | 2001-08-17 | Injections |
Country Status (5)
Country | Link |
---|---|
US (1) | US7396841B2 (en) |
EP (1) | EP1310252A4 (en) |
AU (1) | AU2001278755A1 (en) |
CA (1) | CA2419067C (en) |
WO (1) | WO2002015908A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY137726A (en) * | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
AU2003237598A1 (en) * | 2002-06-03 | 2003-12-19 | Aurobindo Pharma Ltd. | Process for the preparation of highly pure rabeprazole sodium salt |
AU2003299795A1 (en) * | 2002-12-20 | 2004-07-22 | Xeris Pharmaceuticals, Inc. | Intracutaneous injection |
ATE466579T1 (en) * | 2003-11-05 | 2010-05-15 | Lyka Labs Ltd | METHOD FOR PRODUCING BENZIMIDAZOLES |
TW200526268A (en) * | 2003-12-17 | 2005-08-16 | Takeda Pharmaceutical | Injectable composition |
WO2006106903A1 (en) | 2005-03-31 | 2006-10-12 | Chugai Seiyaku Kabushiki Kaisha | sc(Fv)2 STRUCTURAL ISOMERS |
US9241994B2 (en) | 2005-06-10 | 2016-01-26 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical compositions containing sc(Fv)2 |
KR101367544B1 (en) | 2005-06-10 | 2014-02-26 | 추가이 세이야쿠 가부시키가이샤 | Stabilizer for protein preparation comprising meglumine and use thereof |
US7598273B2 (en) * | 2005-10-06 | 2009-10-06 | Auspex Pharmaceuticals, Inc | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties |
US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
US20120046225A1 (en) | 2010-07-19 | 2012-02-23 | The Regents Of The University Of Colorado, A Body Corporate | Stable glucagon formulations for the treatment of hypoglycemia |
CN105853348B (en) | 2011-03-10 | 2019-08-30 | Xeris药物公司 | Parenteral injection stablizing solution |
MX349383B (en) | 2011-10-31 | 2017-07-26 | Xeris Pharmaceuticals Inc | Formulations for the treatment of diabetes. |
US9125805B2 (en) | 2012-06-27 | 2015-09-08 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of small molecule drugs |
US9018162B2 (en) | 2013-02-06 | 2015-04-28 | Xeris Pharmaceuticals, Inc. | Methods for rapidly treating severe hypoglycemia |
JP6982495B2 (en) | 2014-08-06 | 2021-12-17 | ゼリス ファーマシューティカルズ インコーポレイテッド | Syringes, kits, and methods for intradermal and / or subcutaneous injection of paste |
US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
CN105017352B (en) * | 2015-07-02 | 2017-08-22 | 广东药科大学 | A kind of indole alkaloid glucoside and its application |
US11590205B2 (en) | 2015-09-25 | 2023-02-28 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
BR112019024987A2 (en) | 2017-06-02 | 2020-06-16 | Xeris Pharmaceuticals, Inc. | SMALL MOLECULE DRUG FORMULATIONS RESISTANT TO PRECIPITATION |
CN109381435B (en) * | 2017-08-02 | 2021-11-19 | 南京斯帕克医药科技有限公司 | Dexlansoprazole freeze-dried powder injection, preparation method and application thereof |
CN113069421A (en) * | 2021-03-29 | 2021-07-06 | 海南锦瑞制药有限公司 | Lansoprazole for injection |
CN113679680B (en) * | 2021-09-28 | 2022-12-30 | 海南葫芦娃药业集团股份有限公司 | Lansoprazole freeze-dried powder for injection and preparation method thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5223515A (en) | 1988-08-18 | 1993-06-29 | Takeda Chemical Industries, Ltd. | Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
DK399389A (en) | 1988-08-18 | 1990-02-19 | Takeda Chemical Industries Ltd | INJECTABLE SOLUTIONS |
JPH0720865B2 (en) | 1989-02-10 | 1995-03-08 | 武田薬品工業株式会社 | Antibacterial agent |
ES2066120T3 (en) * | 1989-02-10 | 1995-03-01 | Takeda Chemical Industries Ltd | USE OF BENCIMIDAZOLE DERIVATIVES AS ANTIBACTERIAL AGENTS. |
JP3954115B2 (en) | 1992-07-28 | 2007-08-08 | アストラゼネカ・アクチエボラーグ | Injection and injection kit |
EP0652751B1 (en) | 1992-07-28 | 1996-10-23 | Astra Aktiebolag | Injection and injection kit containing omeprazole and its analogs |
JPH07157440A (en) | 1993-10-15 | 1995-06-20 | Takeda Chem Ind Ltd | Composition for medicine |
TW280770B (en) | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
JP3859742B2 (en) | 1995-04-14 | 2006-12-20 | 武田薬品工業株式会社 | Liver disease treatment |
FR2740686B1 (en) | 1995-11-03 | 1998-01-16 | Sanofi Sa | STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION |
TW385306B (en) | 1996-11-14 | 2000-03-21 | Takeda Chemical Industries Ltd | Method for producing crystals of benzimidazole derivatives |
SE510643C2 (en) | 1997-06-27 | 1999-06-14 | Astra Ab | Thermodynamically stable omeprazole sodium form B |
WO1999018959A1 (en) * | 1997-10-14 | 1999-04-22 | Eisai Co., Ltd. | Pharmaceutical formulation comprising glycine as a stabilizer |
CN1141097C (en) | 1998-04-20 | 2004-03-10 | 卫材株式会社 | Stabilized compositions containing benzimidzole-type compounds |
SE9903831D0 (en) * | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
CA2417311C (en) | 2000-08-04 | 2012-07-10 | Takeda Chemical Industries, Ltd. | Crystalline alkali metal salts of lansoprazole and their production and use |
-
2001
- 2001-08-17 CA CA002419067A patent/CA2419067C/en not_active Expired - Fee Related
- 2001-08-17 EP EP01956934A patent/EP1310252A4/en not_active Withdrawn
- 2001-08-17 AU AU2001278755A patent/AU2001278755A1/en not_active Abandoned
- 2001-08-17 US US10/344,805 patent/US7396841B2/en not_active Expired - Fee Related
- 2001-08-17 WO PCT/JP2001/007075 patent/WO2002015908A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20030191157A1 (en) | 2003-10-09 |
EP1310252A1 (en) | 2003-05-14 |
EP1310252A4 (en) | 2009-06-10 |
CA2419067C (en) | 2008-12-23 |
CA2419067A1 (en) | 2002-02-28 |
WO2002015908A1 (en) | 2002-02-28 |
US7396841B2 (en) | 2008-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6419701A (en) | Electropancreatography | |
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2001278755A1 (en) | Injections | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001274548A1 (en) | Syringe | |
AU2001220246A1 (en) | Neckphone | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2002211128A1 (en) | Step-bike | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2002226346A1 (en) | 2-aryl-5-trifluoromethylpyridines | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
AU2001291876A1 (en) | Triazolo-epothilones | |
AU2002214354A1 (en) | Neck-phone | |
AU2001226668A1 (en) | Crankshaft-starter-generator | |
AU2001284173A1 (en) | Calycins |